Screener / SEC EDGAR /CIK 0000873303 /10-K filed Mar 2, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Sarepta Therapeutics, Inc. SRPT

Compare with peers Embed
Filings with the SEC since Apr 1, 2011

1,000 filings, 4 in the last 30 days

SEC filing index

What the 8-Ks said

4 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.

CEO, CFO, COO or CAO: 3 (item 5.02)Auditor change: 0 (item 4.01)Not to be relied on: 0 (item 4.02)Cybersecurity: 0 (item 1.05)Restructuring: 1 (item 2.05)Listing notice: 0 (item 3.01)Impairment: 0 (item 2.06)Debt trigger: 0 (item 2.04)
  • Jul 27, 2026 CEO, CFO, COO or CAOCEO change “(the “Company”) appointed Michael Severino, M.D. as Chief Executive Officer of the Company, effective July 28, 2026 (the “Effective Date”).” 8-K item 5.02 · all documents
  • Feb 25, 2026 CEO, CFO, COO or CAOCEO change “(the “Company”) of his decision to retire as Chief Executive Officer by the end of 2026 or upon the appointment of his replacement.” 8-K item 5.02 · all documents
  • Jul 16, 2025 CEO, CFO, COO or CAOCOO change “On July 14, 2025, the Board appointed Ian Estepan as the Company’s President and Chief Operating Officer, Louise Rodino-Klapac, Ph.” 8-K item 5.02 · all documents
  • Jul 16, 2025 RestructuringReported exit or disposal costs from a restructuring “. Costs Associated with Exit or Disposal Activities. Following an evaluation of its annual combined research and development and selling, general and administrative spend, the Company is undertaking a restructuring that includes a revised cost structure and program portfolio. In connection with those plans, on July 14, 2025, the Board of Directors of the Company (the “Board”) approved a reduction…” 8-K item 2.05 · all documents

From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.

Late filings, 8-K notices and going concern

None found in the last 2 years

All checks
  • Late filing notices (NT 10-K, NT 10-Q)
    No notice in the last 2 years.
  • 8-K notices: listing, impairment, debt trigger
    No item 3.01, 2.06 or 2.04 in the last 2 years.
  • Going-concern language in the 10-K
    No statement of substantial doubt in the latest 10-K.

Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.

Every filing on one line

Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)Planned insider sale (Form 144, 10b5-1)
All 36 events

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind · each form links to sec.gov

FiledFormWhat it is
Nov 13, 2026 13F-HR
Nov 13, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Nov 5, 2026 8-K Quarterly results
Nov 5, 2026 10-Q Quarterly report
Sep 23, 2026 8-K Material agreement signed
Sep 8, 2026 4 Insider trade
Sep 8, 2026 4 Insider trade
Sep 8, 2026 4 Insider trade
Sep 8, 2026 4 Insider trade
Aug 14, 2026 13F-HR
Aug 13, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Aug 5, 2026 8-K Quarterly results
Aug 5, 2026 10-Q Quarterly report
Jul 31, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Jul 30, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Jul 29, 2026 4 Insider trade
Jul 29, 2026 3 New insider
Jul 28, 2026 S-8 Shares registered for employee plans
Jul 27, 2026 8-K Director or officer change, Regulation FD disclosure
Jun 5, 2026 4 Insider trade
Jun 5, 2026 4 Insider trade
Jun 5, 2026 4 Insider trade
Jun 5, 2026 4 Insider trade
Jun 5, 2026 4 Insider trade
Jun 5, 2026 4 Insider trade
Jun 5, 2026 4 Insider trade
Jun 5, 2026 4 Insider trade
Jun 4, 2026 S-8 Shares registered for employee plans
Jun 4, 2026 8-K Director or officer change, Shareholder vote results
May 13, 2026 13F-HR
May 6, 2026 8-K Quarterly results
May 6, 2026 10-Q Quarterly report
Apr 30, 2026 SCHEDULE 13G 5%+ owner (passive)
Apr 29, 2026 SCHEDULE 13G 5%+ owner (passive)
Apr 24, 2026 ARS Annual report to shareholders
Apr 24, 2026 DEFA14A Extra proxy material
Apr 24, 2026 DEF 14A Proxy statement
Mar 27, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Mar 13, 2026 4 Insider trade
Mar 13, 2026 4 Insider trade
Mar 13, 2026 4 Insider trade
Mar 13, 2026 4 Insider trade
Mar 13, 2026 4 Insider trade
Mar 12, 2026 144 Notice of planned insider sale
Mar 11, 2026 4 Insider trade
Mar 11, 2026 4 Insider trade
Mar 11, 2026 4 Insider trade
Mar 11, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 2, 2026 4 Insider trade
Mar 2, 2026 10-K Annual report
Feb 27, 2026 4 Insider trade
Feb 27, 2026 4 Insider trade
Feb 25, 2026 8-K Director or officer change
Feb 25, 2026 8-K Quarterly results
Feb 13, 2026 13F-HR
Feb 13, 2026 SCHEDULE 13G 5%+ owner (passive)
Jan 29, 2026 4 Insider trade
Jan 29, 2026 4 Insider trade
Jan 21, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Jan 12, 2026 8-K Quarterly results
Dec 19, 2025 4 Insider trade
Dec 19, 2025 8-K Material agreement signed, New debt or obligation
Dec 18, 2025 4 Insider trade
Dec 16, 2025 144 Notice of planned insider sale
Dec 11, 2025 8-K Unregistered share sale, Other events
Dec 10, 2025 4 Insider trade
Dec 9, 2025 4 Insider trade
Dec 8, 2025 8-K Director or officer change
Dec 2, 2025 4 Insider trade
Nov 19, 2025 4 Insider trade
Nov 14, 2025 SCHEDULE 13G/A 5%+ owner (passive), amended
Nov 6, 2025 10-Q Quarterly report
Nov 3, 2025 8-K Quarterly results
Sep 8, 2025 SCHEDULE 13G/A 5%+ owner (passive), amended
Sep 5, 2025 4 Insider trade
Sep 5, 2025 4 Insider trade
Sep 5, 2025 4 Insider trade
Sep 5, 2025 4 Insider trade
Aug 29, 2025 8-K Material agreement signed, New debt or obligation, Other events
Aug 21, 2025 8-K Unregistered share sale
Aug 15, 2025 SCHEDULE 13D/A 5%+ owner (active), amended
Aug 13, 2025 SCHEDULE 13G/A 5%+ owner (passive), amended
Aug 13, 2025 8-K Director or officer change
Aug 13, 2025 144 Notice of planned insider sale
Aug 6, 2025 S-8 Shares registered for employee plans
Aug 6, 2025 4 Insider trade
Aug 6, 2025 4 Insider trade
Aug 6, 2025 4 Insider trade
Aug 6, 2025 10-Q Quarterly report
Aug 4, 2025 4 Insider trade
Aug 4, 2025 3 New insider
Jul 25, 2025 SCHEDULE 13G/A 5%+ owner (passive), amended
Jul 25, 2025 SCHEDULE 13G 5%+ owner (passive)
Jul 21, 2025 8-K Other events
Jul 16, 2025 8-K Quarterly results, Restructuring or exit costs, Director or officer change
Jun 6, 2025 8-K Director or officer change, Shareholder vote results
Show the other 75 filings on this page

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Sources

SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.

Also

Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SRPT/export.csv") into a cell.

Next:Earnings releases
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.